Individuals continue to contact our Firm, after they or a loved one allegedly suffered a frightening episode of Pradaxa internal bleeding. We are pleased to see continued progress in this litigation.
New York, NY (PRWEB) September 15, 2013
Nearly 1,500 Pradaxa lawsuits http://www.pradaxalawsuithelp.com/ filed on behalf of alleged victims of Pradaxa internal bleeding continue to move forward in a federal multidistrict litigation underway in U.S. District Court, Southern District of Illinois. According to court records, the litigation’s most recent Status Conference was convened on September 4, 2013, at which time the Court was provided with an update regarding the scheduling of depositions, as well as the status of certain discovery issues. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)
“Individuals continue to contact our Firm, after they or a loved one allegedly suffered a frightening episode of Pradaxa internal bleeding. We are pleased to see continued progress in this litigation,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free legal evaluations to alleged victims of Pradaxa bleeding.
Pradaxa Bleeding Litigation
Pradaxa was approved in October 2010 to treat patients with atrial fibrillation, and was touted as an improvement over decades-old warfarin, a blood thinner sold under the brand name, Coumadin. However, according to a recent Bloomberg.com report, Pradaxa has been the subject of a number of safety alerts in the U.S. and abroad, most of which related to Pradaxa bleeding side effects. While warfarin bleeding can be stopped by the administration of vitamin k, there is no readily available antidote to stop Pradaxa internal bleeding .* In January, a study published by the Institute for Safe Medicine Practices reported that Pradaxa users who experience internal bleeding are 5 times more likely to die compared to those who suffer internal bleeding while using warfarin.
According to court documents, 1,495 Pradaxa lawsuits are pending in the Southern District of Illinois. All of the claims allege that Boehringer Ingelheim failed to provide adequate warnings regarding Pradaxa bleeding, particularly the lack of an antidote. The first bellwether trial in the Pradaxa litigation is scheduled to start in September 2014.
Alleged victims of Pradaxa bleeding may be entitled to compensation for their medical bills, lost wages, pain and suffering and more. Click Here to contact a Pradaxa lawyer at Bernstein Liebhard LLP. To arrange for a free legal consultation, please call 800-511-5092.
*bloomberg.com/news/2012-12-11/boehringer-sued-by-hundreds-over-bleeding-tied-to-pradaxa.html, Bloomberg.com, December 11, 2012
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com